Literature DB >> 15178937

Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.

Andrew Kertesz1, David Munoz.   

Abstract

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) were described as separate entities, but prior to that an extrapyramidal variety of Pick's disease was recognized. Subsequently a pathological overlap between these conditions and clinical overlap between frontotemporal dementia, primary progressive aphasia, corticobasal degeneration syndrome and more recently PSP was recognized. Initially only the movement disorder had been emphasized, but now the behavioral and language symptoms are considered common. The syndromes of frontotemporal dementia/Pick's disease can be produced by underlying CBD, PSP or Pick pathology as well as with neural inclusions of the motor neuron disease type. The concept of this overlap has been confirmed genetically finding a similar spectrum of pathology with different tau mutations and even with tau negative pathology, which could be a deficiency of normal tau. The overlap of CBD with PSP and both with PPA and FTD allows to consider these relatively rare conditions as part of a more commonly occurring degenerative disease than previously recognized. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178937     DOI: 10.1159/000077155

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  21 in total

1.  Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults.

Authors:  Judy Pa; Katherine L Possin; Stephen M Wilson; Lovingly C Quitania; Joel H Kramer; Adam L Boxer; Michael W Weiner; Julene K Johnson
Journal:  J Int Neuropsychol Soc       Date:  2010-04-07       Impact factor: 2.892

2.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.

Authors:  Deepak M Sampathu; Manuela Neumann; Linda K Kwong; Thomas T Chou; Matthew Micsenyi; Adam Truax; Jennifer Bruce; Murray Grossman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

3.  Extrapyramidal signs in the primary progressive aphasias.

Authors:  Sarah A Kremen; Mario F Mendez; Po-Heng Tsai; Edmond Teng
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-02       Impact factor: 2.035

4.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.

Authors:  A Padovani; B Borroni; S M Brambati; C Agosti; M Broli; R Alonso; P Scifo; G Bellelli; A Alberici; R Gasparotti; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  Apathy in corticobasal degeneration: possible parietal involvement.

Authors:  Rita Moretti; R Caberlotto; R Signori
Journal:  Funct Neurol       Date:  2017 Oct/Dec

Review 6.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

7.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

8.  Sound naming in neurodegenerative disease.

Authors:  Maggie L Chow; Simona M Brambati; Maria Luisa Gorno-Tempini; Bruce L Miller; Julene K Johnson
Journal:  Brain Cogn       Date:  2010-01-20       Impact factor: 2.310

9.  Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology.

Authors:  Leo F McCluskey; Lauren B Elman; Maria Martinez-Lage; Vivianna Van Deerlin; Wuxing Yuan; Dana Clay; Andrew Siderowf; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-01

Review 10.  Update on frontotemporal dementia.

Authors:  Zoe Arvanitakis
Journal:  Neurologist       Date:  2010-01       Impact factor: 1.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.